New development mechanism and drug research of esophageal squamous cell carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200067037

Enrollment

Unknown

Registered

2022-12-24

Start date

2022-12-22

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carcinoma

Interventions

Study Group:none

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with esophageal squamous cell carcinoma over 18 years of age and under 90 years of age who meet surgical criteria

Exclusion criteria

Exclusion criteria: 2. Patients who are not found to have esophageal squamous cell carcinoma during surgery 3. Patients whose physical condition is not suitable for surgery

Design outcomes

Primary

Measure	Time frame
Untargeted Metabolomics in plasma;	—

Countries

China

Contacts

Public ContactJu Zhu

The First Hospital of Chongqing Medical University

kevin_zhu@hospital.cqmu.edu.cn15310145116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026